等待開盤 08-11 09:30:00 美东时间
-0.045
-1.11%
OraSure Technologies (NASDAQ:OSUR) sees Q3 sales of $29.500 million-$32.500 million vs $31.143 million analyst estimate.
08-06 04:42
OraSure 2026年第二季度营收3,063.9万美元,同比下降2%,稀释EPS为0.09美元;或有对价负债减少推动GAAP转盈,但非GAAP经营亏损扩大至1,474万美元。
08-05 21:07
OraSure Technologies, Inc. (NASDAQ:OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its second generation OraQuick™ Ebola...
07-22 04:31
Orasure Technologies ( ($OSUR) ) just unveiled an update. On June 11, 2026, Ora...
06-11 21:27
OraSure Technologies announced FDA clearance for its Colli-Pee™•Dx Urine Collection Kit, designed for at-home urine sample collection to detect STIs like Chlamydia, gonorrhea, trichomoniasis, and mycoplasma. The kit, developed with Roche’s cobas® molecular testing systems, enables private, convenient sample collection in any setting, improving accessibility for underserved populations and supporting large-scale STI screening programs.
06-11 12:00
Orasure (($OSUR)) has held its Q1 earnings call. Read on for the main highlight...
05-08 10:19
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03